
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5480693
[patent_doc_number] => 20090203650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'USE OF PHYTATE AS AGENT INHIBITING DISSOLUTION OF CRYSTALS OF CALCIUM SALTS FOR THE PREVENTION OF OSTEOPOROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/302964
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2660
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203650.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302964 | Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis | May 29, 2007 | Issued |
Array
(
[id] => 5343366
[patent_doc_number] => 20090182016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'OPTICAL ENANTIOMERS OF PHENYRAMIDOL AND PROCESS FOR CHIRAL SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 12/301710
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10607
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301710
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301710 | OPTICAL ENANTIOMERS OF PHENYRAMIDOL AND PROCESS FOR CHIRAL SYNTHESIS | May 20, 2007 | Abandoned |
Array
(
[id] => 5231468
[patent_doc_number] => 20070293576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/745928
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26166
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293576.pdf
[firstpage_image] =>[orig_patent_app_number] => 11745928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/745928 | Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease | May 7, 2007 | Abandoned |
Array
(
[id] => 4734480
[patent_doc_number] => 20080051460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'PHARMACEUTICAL METHODS, DOSING REGIMES AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/743522
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051460.pdf
[firstpage_image] =>[orig_patent_app_number] => 11743522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/743522 | PHARMACEUTICAL METHODS, DOSING REGIMES AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | May 1, 2007 | Abandoned |
Array
(
[id] => 5485819
[patent_doc_number] => 20090275584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'BIOCIDAL COMBINATIONS COMPRISING IMAZALIL'
[patent_app_type] => utility
[patent_app_number] => 12/299130
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5493
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275584.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299130
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299130 | BIOCIDAL COMBINATIONS COMPRISING IMAZALIL | May 1, 2007 | Abandoned |
Array
(
[id] => 5285463
[patent_doc_number] => 20090099138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'PHARMACEUTICAL COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 11/741411
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8748
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11741411
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/741411 | PHARMACEUTICAL COMBINATION | Apr 26, 2007 | Abandoned |
Array
(
[id] => 6267223
[patent_doc_number] => 20100298340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies'
[patent_app_type] => utility
[patent_app_number] => 12/296771
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25748
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296771 | Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies | Apr 11, 2007 | Abandoned |
Array
(
[id] => 5126401
[patent_doc_number] => 20070238672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'CO-ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS AND ANTICONVULSANTS'
[patent_app_type] => utility
[patent_app_number] => 11/696623
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18315
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238672.pdf
[firstpage_image] =>[orig_patent_app_number] => 11696623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696623 | CO-ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS AND ANTICONVULSANTS | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5380384
[patent_doc_number] => 20090192223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'GIP SECRETION INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/298366
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2349
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192223.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298366
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298366 | GIP SECRETION INHIBITOR | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5410792
[patent_doc_number] => 20090124691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'INHIBITOR OF INCREASE IN POSTPRANDIAL BLOOD INSULIN LEVEL'
[patent_app_type] => utility
[patent_app_number] => 12/298424
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2312
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298424 | INHIBITOR OF INCREASE IN POSTPRANDIAL BLOOD INSULIN LEVEL | Apr 3, 2007 | Abandoned |
Array
(
[id] => 6592695
[patent_doc_number] => 20100130581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/295187
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22970
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295187 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | Mar 29, 2007 | Abandoned |
Array
(
[id] => 5187991
[patent_doc_number] => 20070166299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'TREATMENT FOR EMBOLIC STROKE'
[patent_app_type] => utility
[patent_app_number] => 11/693418
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14300
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693418 | TREATMENT FOR EMBOLIC STROKE | Mar 28, 2007 | Abandoned |
Array
(
[id] => 5355510
[patent_doc_number] => 20090186854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'S-ALKYLISOTHIOURONIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/294016
[patent_app_country] => US
[patent_app_date] => 2007-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12284
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294016 | S-ALKYLISOTHIOURONIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | Mar 24, 2007 | Abandoned |
Array
(
[id] => 5126515
[patent_doc_number] => 20070238786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/681082
[patent_app_country] => US
[patent_app_date] => 2007-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26165
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11681082
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/681082 | Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease | Feb 28, 2007 | Abandoned |
Array
(
[id] => 5343326
[patent_doc_number] => 20090181976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Use of Compounds Binding to the Sigma Receptor for the Treatment of Metabolic Syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/224254
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6617
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224254
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224254 | Use of Compounds Binding to the Sigma Receptor for the Treatment of Metabolic Syndrome | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5126516
[patent_doc_number] => 20070238787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/680436
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26182
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238787.pdf
[firstpage_image] =>[orig_patent_app_number] => 11680436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/680436 | Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5360438
[patent_doc_number] => 20090035232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC'
[patent_app_type] => utility
[patent_app_number] => 12/279616
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279616
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279616 | Fixed-dose association of phytate and zinc | Feb 13, 2007 | Issued |
Array
(
[id] => 5392204
[patent_doc_number] => 20090209517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 12/279027
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4552
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279027 | Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders | Feb 13, 2007 | Abandoned |
Array
(
[id] => 5360438
[patent_doc_number] => 20090035232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC'
[patent_app_type] => utility
[patent_app_number] => 12/279616
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279616
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279616 | Fixed-dose association of phytate and zinc | Feb 13, 2007 | Issued |
Array
(
[id] => 4853328
[patent_doc_number] => 20080319071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/279510
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8105
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0319/20080319071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279510 | Nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders | Feb 12, 2007 | Issued |